4.7 Article

CoMut: visualizing integrated molecular information with comutation plots

Journal

BIOINFORMATICS
Volume 36, Issue 15, Pages 4348-4349

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bioinformatics/btaa554

Keywords

-

Funding

  1. National Science Foundation [GRFP DGE1144152]
  2. National Institutes of Health [T32 GM008313, R37 CA222574, R01 CA227388, U01 CA233100]
  3. PCF-Movember Challenge Award

Ask authors/readers for more resources

Motivation: Large-scale sequencing studies have created a need to succinctly visualize genomic characteristics of patient cohorts linked to widely variable phenotypic information. This is often done by visualizing the co-occurrence of variants with comutation plots. Current tools lack the ability to create highly customizable and publication quality comutation plots from arbitrary user data. Results: We developed CoMut, a stand-alone, object-oriented Python package that creates comutation plots from arbitrary input data, including categorical data, continuous data, bar graphs, side bar graphs and data that describes relationships between samples.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Punctuated Evolution of Prostate Cancer Genomes

Sylvan C. Baca, Davide Prandi, Michael S. Lawrence, Juan Miguel Mosquera, Alessandro Romanel, Yotam Drier, Kyung Park, Naoki Kitabayashi, Theresa Y. MacDonald, Mahmoud Ghandi, Eliezer Van Allen, Gregory V. Kryukov, Andrea Sboner, Jean-Philippe Theurillat, T. David Soong, Elizabeth Nickerson, Daniel Auclair, Ashutosh Tewari, Himisha Beltran, Robert C. Onofrio, Gunther Boysen, Candace Guiducci, Christopher E. Barbieri, Kristian Cibulskis, Andrey Sivachenko, Scott L. Carter, Gordon Saksena, Douglas Voet, Alex H. Ramos, Wendy Winckler, Michelle Cipicchio, Kristin Ardlie, Philip W. Kantoff, Michael F. Berger, Stacey B. Gabriel, Todd R. Golub, Matthew Meyerson, Eric S. Lander, Olivier Elemento, Gad Getz, Francesca Demichelis, Mark A. Rubin, Levi A. Garraway

Article Oncology

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

Jonathan E. Rosenberg, Richard M. Bambury, Eliezer M. Van Allen, Harry A. Drabkin, Primo N. Lara, Andrea L. Harzstark, Nikhil Wagle, Robert A. Figlin, Gregory W. Smith, Levi A. Garraway, Toni Choueiri, Fredrik Erlandsson, Damian A. Laber

INVESTIGATIONAL NEW DRUGS (2014)

Article Oncology

MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition

Nikhil Wagle, Eliezer M. Van Allen, Daniel J. Treacy, Dennie T. Frederick, Zachary A. Cooper, Amaro Taylor-Weiner, Mara Rosenberg, Eva M. Goetz, Ryan J. Sullivan, Deborah N. Farlow, Dennis C. Friedrich, Kristin Anderka, Danielle Perrin, Cory M. Johannessen, Aaron McKenna, Kristian Cibulskis, Gregory Kryukov, Eran Hodis, Donald P. Lawrence, Sheila Fisher, Gad Getz, Stacey B. Gabriel, Scott L. Carter, Keith T. Flaherty, Jennifer A. Wargo, Levi A. Garraway

CANCER DISCOVERY (2014)

Article Oncology

The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma

Eliezer M. Van Allen, Nikhil Wagle, Antje Sucker, Daniel J. Treacy, Cory M. Johannessen, Eva M. Goetz, Chelsea S. Place, Amaro Taylor-Weiner, Steven Whittaker, Gregory V. Kryukov, Eran Hodis, Mara Rosenberg, Aaron McKenna, Kristian Cibulskis, Deborah Farlow, Lisa Zimmer, Uwe Hillen, Ralf Gutzmer, Simone M. Goldinger, Selma Ugurel, Helen J. Gogas, Friederike Egberts, Carola Berking, Uwe Trefzer, Carmen Loquai, Benjamin Weide, Jessica C. Hassel, Stacey B. Gabriel, Scott L. Carter, Gad Getz, Levi A. Garraway, Dirk Schadendorf

CANCER DISCOVERY (2014)

Article Multidisciplinary Sciences

Seasonal changes in diet and chemical defense in the Climbing Mantella frog (Mantella laevigata)

Nora A. Moskowitz, Alexandre B. Roland, Eva K. Fischer, Ndimbintsoa Ranaivorazo, Charles Vidoudez, Marianne T. Aguilar, Sophia M. Caldera, Jacqueline Chea, Miruna G. Cristus, Jett P. Crowdis, Bluye DeMessie, Caroline R. desJardins-Park, Audrey H. Effenberger, Felipe Flores, Michael Giles, Emma Y. He, Nike S. Izmaylov, ChangWon C. Lee, Nicholas A. Pagel, Krystal K. Phu, Leah U. Rosen, Danielle A. Seda, Yong Shen, Santiago Vargas, Andrew W. Murray, Eden Abebe, Sunia A. Trauger, David A. Donoso, Miguel Vences, Lauren A. O'Connell

PLOS ONE (2018)

Review Biochemistry & Molecular Biology

Genomic correlates of response to immune checkpoint blockade

Tanya E. Keenan, Kelly P. Burke, Eliezer M. Van Allen

NATURE MEDICINE (2019)

Article Genetics & Heredity

Identification of cancer driver genes based on nucleotide context

Felix Dietlein, Donate Weghorn, Amaro Taylor-Weiner, Andre Richters, Brendan Reardon, David Liu, Eric S. Lander, Eliezer M. Van Allen, Shamil R. Sunyaev

NATURE GENETICS (2020)

Article Cell Biology

Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer

Alok K. Tewari, Alexander T. M. Cheung, Jett Crowdis, Jake R. Conway, Sabrina Y. Camp, Stephanie A. Wankowicz, Dimitri G. Livitz, Jihye Park, Rosina T. Lis, Alice Bosma-Moody, Meng Xiao He, Saud H. AlDubayan, Zhenwei Zhang, Rana R. McKay, Ignaty Leshchiner, Myles Brown, Steven P. Balk, Gad Getz, Mary-Ellen Taplin, Eliezer M. Van Allen

Summary: The study conducted whole-exome and transcriptome sequencing on pre-treatment tumor biopsies from prostate cancer patients receiving intensive anti-androgen therapies, identifying distinct molecular features in exceptional responders and non-responders, such as clonal SPOP mutation and TP53 mutation. These findings may inform prospective validation studies to improve patient stratification and treatment strategies in high-risk localized prostate cancer.

CELL REPORTS (2021)

Article Multidisciplinary Sciences

Artificial intelligence-aided clinical annotation of a large multi-cancer genomic dataset

Kenneth L. Kehl, Wenxin Xu, Alexander Gusev, Ziad Bakouny, Toni K. Choueiri, Irbaz Bin Riaz, Haitham Elmarakeby, Eliezer M. Van Allen, Deborah Schrag

Summary: By training natural language processing models, researchers have successfully extracted outcome information for participants in precision oncology studies, accelerating research on the correlation between cancer-related biomarkers and clinical endpoints.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Genome-wide analysis of somatic noncoding mutation patterns in cancer

Felix Dietlein, Alex B. Wang, Christian Fagre, Anran Tang, Nicolle J. M. Besselink, Edwin Cuppen, Chunliang Li, Shamil R. Sunyaev, James T. Neal, Eliezer M. Van Allen

Summary: We established a comprehensive map of somatic mutation events in the whole cancer genomes, representing 19 tumor types. We found that protein-coding events and noncoding events play different roles in tumors, and noncoding events may be potential drivers. We also discovered that XBP1 mutations primarily accumulate outside the gene's promoter and impact gene expression.

SCIENCE (2022)

Editorial Material Oncology

A Process Framework for Ethically Deploying Artificial Intelligence in Oncology

Andrew Hantel, Dillon D. Clancy, Kenneth L. Kehl, Jonathan M. Marron, Eliezer M. Van Allen, Gregory A. Abel

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

Seyram A. Doe-Tetteh, Sabrina Y. Camp, Dalicia Reales, Jett Crowdis, Anne Marie Noronha, Bernadette Wolff, Tina Alano, Jesse Galle, S. Duygu Selcuklu, Agnes Viale, Nicholas D. Socci, Ying L. Liu, William P. Tew, Carol Aghajanian, Marc Ladanyi, Meng Xiao He, Saud H. AlDubayan, Roei David Mazor, Ofer Shpilberg, Oshrat Hershkovitz-Rokah, Jose A. Riancho, Jose L. Hernandez, M. Carmen Gonzalez-Vela, Justin J. Buthorn, Manda Wilson, Amy E. Webber, Mariko Yabe, Kseniya Petrova-Drus, Marc Rosenblum, Benjamin H. Durham, Omar Abdel-Wahab, Michael F. Berger, Mark T. A. Donoghue, Andrew L. Kung, Julia Glade Bender, Neerav N. Shukla, Samuel A. Funt, Ahmet Dogan, Robert A. Soslow, Hikmat Al-Ahmadie, Darren R. Feldman, Eliezer M. Van Allen, Eli L. Diamond, David B. Solit

Summary: To overcome barriers to genomic testing for rare cancer patients, a program providing free clinical tumor genomic testing was initiated. Patients with specific rare cancers were recruited through social media outreach and engagement with advocacy groups. Tumors were analyzed using next-generation sequencing assay, with results reported to patients and local physicians. Whole-exome sequencing was performed for female patients with germ cell tumors to define the genomic landscape of this rare cancer subtype.

CLINICAL CANCER RESEARCH (2023)

Article Genetics & Heredity

Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium

Jonathan S. Berg, Laura M. Amendola, Christine Eng, Eliezer Van Allen, Stacy W. Gray, Nikhil Wagle, Heidi L. Rehm, Elizabeth T. DeChene, Matthew C. Dulik, Fuki M. Hisama, Wylie Burke, Nancy B. Spinner, Levi Garraway, Robert C. Green, Sharon Plon, James P. Evans, Gail P. Jarvik

GENETICS IN MEDICINE (2013)

No Data Available